Infective exacerbations of chronic bronchitis: relation between bacteriologic etiology and lung function
- PMID: 9631791
- DOI: 10.1378/chest.113.6.1542
Infective exacerbations of chronic bronchitis: relation between bacteriologic etiology and lung function
Abstract
Study objective: In patients with severe COPD, acute infective exacerbations are frequent. Streptococcus pneumoniae and Haemophilus influenzae are the most commonly isolated bacteria in sputum cultures from these patients. We hypothesized that in patients with advanced disease, Gram-negative bacteria other than H influenzae play at least an equally important role.
Methods: We evaluated clinical data and sputum culture results from 211 unselected COPD patients admitted to our hospital with an acute infective exacerbation of COPD. One hundred twelve patients fulfilled our protocol criteria of reliable microbiologic results and reproducible lung function tests; the patients were categorized according to the recently published three stages of severity.
Results: Lung function tests revealed an FEV1 of > or =50% of the predicted value in 30 patients (stage I), an FEV1 of 35% to <50% of the predicted value in 30 patients (stage II), and an FEV1 of < or =35% of the predicted value in 34 patients (stage III). Bacteria were classified into three groups: group 1 contained S pneumoniae and other Gram-positive cocci; group 2, H influenzae and Moraxella catarrhalis; and group 3, Enterobacteriaceae and Pseudomonas spp. For all patients together, the most frequently isolated bacteria were group 3 organisms (Enterobacteriaceae and Pseudomonas spp, 48.2%), followed by group 1 organisms (S pneumoniae and other Gram-positive cocci, 30.4%), and group 2 organisms (H influenzae and M catarrhalis, 21.4%). In stage I patients, 14 of 30 had bacteria from group 1, seven of 30 had group 2, and nine of 30 had group 3. In stage II patients, eight of 30 had group 1 bacteria, 10 of 30 had group 2, and 12 of 30 had group 3. In stage III patients, 12 of 52 had group 1 bacteria, seven of 52 had group 2, and 22 of 52 had group 3. The three groups of bacteria causing infective exacerbations were unevenly distributed among the three severity stages of lung function (p=0.016).
Conclusion: There is a correlation between deterioration of lung function and the bacteria isolated from patients with infective exacerbations of COPD. In acute infective exacerbations, Enterobacteriaceae and Pseudomonas spp are the predominant bacteria in patients with an FEV1 < or =35% of the predicted value.
Comment in
-
Infective exacerbations of COPD.Chest. 1999 May;115(5):1481. doi: 10.1378/chest.115.5.1481. Chest. 1999. PMID: 10334183 No abstract available.
Similar articles
-
Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD. Study Group of Bacterial Infection in COPD.Chest. 1999 Jul;116(1):40-6. doi: 10.1378/chest.116.1.40. Chest. 1999. PMID: 10424501
-
Acute exacerbation of chronic bronchitis: what is the clinical significance of pathogenic bacteria in sputum cultures?Chest. 2000 Dec;118(6):1523-5. doi: 10.1378/chest.118.6.1523-a. Chest. 2000. PMID: 11115428 No abstract available.
-
Microbes responsible for acute exacerbation of COPD.Mymensingh Med J. 2010 Oct;19(4):576-85. Mymensingh Med J. 2010. PMID: 20956903
-
Bronchial hyperresponsiveness and bacterial respiratory infections.Clin Ther. 1991 Jan-Feb;13(1):157-71. Clin Ther. 1991. PMID: 1709390 Review.
-
Infection in acute exacerbations of chronic bronchitis: a clinical perspective.Respir Med. 1999 Dec;93(12):845-50. doi: 10.1016/s0954-6111(99)90048-3. Respir Med. 1999. PMID: 10653044 Free PMC article. Review.
Cited by
-
Physiological and radiological characterisation of patients diagnosed with chronic obstructive pulmonary disease in primary care.Thorax. 2000 Aug;55(8):635-42. doi: 10.1136/thorax.55.8.635. Thorax. 2000. PMID: 10899238 Free PMC article.
-
Solubility and Dissolution Enhancement of Dexibuprofen with Hydroxypropylbetacyclodextrin (HPβCD) and Poloxamers (188/407) Inclusion Complexes: Preparation and In Vitro Characterization.Polymers (Basel). 2022 Jan 31;14(3):579. doi: 10.3390/polym14030579. Polymers (Basel). 2022. PMID: 35160569 Free PMC article.
-
Bacterial infections in acute exacerbation of chronic obstructive pulmonary disease: a systematic review and meta-analysis.Infection. 2020 Feb;48(1):19-35. doi: 10.1007/s15010-019-01350-1. Epub 2019 Sep 3. Infection. 2020. PMID: 31482316
-
The chronic obstructive pulmonary disease exacerbation.Clin Chest Med. 2000 Dec;21(4):705-21. doi: 10.1016/s0272-5231(05)70179-9. Clin Chest Med. 2000. PMID: 11194781 Free PMC article. Review.
-
Chronic obstructive pulmonary disease: role of bacteria and updated guide to antibacterial selection in the older patient.Drugs Aging. 2009;26(12):985-95. doi: 10.2165/11315700-000000000-00000. Drugs Aging. 2009. PMID: 19929027 Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous